Moberg Pharma Ab Is A Swedish Pharmaceutical Company Based In Stockholmfounded In 2006The Company Specializes In Developing And Commercializing Medical Productswith A Primary Focus On Dermatological Treatmentsits Flagship Productmob 015Is A Topical Treatment For Nail Fungus That Has Shown A High Efficacy Rate In Clinical Trialsmob 015 Is Marketed As Terclara In Sweden And Norwaywhere It Has Become The Market Leadercapturing A Significant Share Shortly After Its Launch Moberg Pharma Aims To Establish Mob 015 As The Leading Treatment For Nail Fungus And Plans To Expand Its Product Portfolio By Developing Or Acquiring Additional Products In Related Areasthe Company Has A Strong Presence In Europeparticularly In Sweden And Norwayand Has Formed Commercial Agreements To Enhance Its Market Reachwith A Small Team Of About 10 Employeesmoberg Pharma Is Focused On Building A Specialty Pharmaceutical Company And Is Well Positioned For Future Growth In Global Markets
No conferences found for this company.
| Company Name | Moberg Pharma North America Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
